The Keck School of Medicine of the University of Southern California teaches and trains physicians, biomedical scientists and other healthcare professionals, conducts medical research, and treats patients. Founded in 1885, it is the second oldest medical school in California after the UCSF School of Medicine.

During the past decade, USC Keck School of Medicine conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 45 clinical trials were completed, i.e. on average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 31 clinical trials were completed. i.e. 53.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USC Keck School of Medicine" #1 sponsor was "University of Southern California" with 17 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Pfizer" with 8 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Washington University School of Medicine" with 5 trials sponsored. Other sponsors include 116 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USC Keck School of Medicine" #1 collaborator was "University of Southern California" with 7 trials as a collaborator, "National Institute on Aging (NIA)" with 5 trials as a collaborator, "Alzheimer's Association" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 115 trials.

According to Clinical.Site data, the most researched conditions in "USC Keck School of Medicine" are "Atopic Dermatitis" (7 trials), "Cervical Dystonia" (6 trials), "Alzheimer's Disease" (5 trials), "Dementia" (4 trials) and "Heart Failure" (4 trials). Many other conditions were trialed in "USC Keck School of Medicine" in a lesser frequency.

Most popular intervention types in "USC Keck School of Medicine" are "Drug" (107 trials), "Device" (28 trials), "Biological" (23 trials), "Other" (21 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "placebo" (5 trials), "Botulinum toxin type A" (4 trials), "Lebrikizumab" (3 trials) and "Automated Whole Breast Ultrasound" (2 trials). Other intervention names were less common.

The vast majority of trials in "USC Keck School of Medicine" are 153 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 58 active trials in "USC Keck School of Medicine". 2 are not yet recruiting, 38 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 82 completed trials in USC Keck School of Medicine, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in USC Keck School of Medicine, 12 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 32 trials that are defined as “Not Applicable".